drugset / Trial / NCT06392152
Efficacy of Focal Primaquine Mass Administration for Eliminating Plasmodium Vivax Malaria in Northern Myanmar
Unknown
1208 enrolled
Pyae Linn Aung
Mahidol University · collabUniversity of South Florida · collab
Non-randomizedCrossoverSingle-blindTreatment
Summary
Plasmodium vivax has become the predominant species in the Greater Mekong Subregion and is a major challenge for regional malaria elimination. Mass primaquine administration has played a decisive role in malaria elimination in many temperate zone countries, but its efficacy in tropical areas remains to be evaluated. This study aims to assess the efficacy of targeted primaquine mass treatment (TPT) for eliminating P. vivax malaria in northern Myanmar.
Timeline
- Start
- 2019-07-01
- Primary completion
- 2024-03-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Primaquine | Small molecule | 0.25 mg/kg | — |